P2RX4 and neoplasm: The results highlight the prognostic role of the ectonucleotidases and purinergic receptors in NSCLCs and show that high levels of CD39 and low levels of CD73 as well as high levels of P2X4 in the tumor are associated with a better survival outcome for the patient.